Otto Cars
- Molecular Medicine top 0.02%
- Pharmacology top 0.05%
- Epidemiology top 0.5%
- Applied Microbiology and Biotechnology top 0.02%
- Infectious Diseases top 1%
- Co-authors
- Elisabeth LöwdinInga OdenholtJohan W. MoutonLena E. FribergCarl NathanDominique L. MonnetChristian G. GiskeHartmut Derendorf
- Topics
- Antibiotics Pharmacokinetics and Efficacy (99 papers)Antibiotic Resistance in Bacteria (83 papers)Pneumonia and Respiratory Infections (45 papers)
- Partner nations
- SwedenUnited StatesNetherlands
In The Last Decade
Otto Cars
181 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Molecular Medicine 4.5k
- Pharmacology 4.3k
- Epidemiology 3.1k
- Applied Microbiology and Biotechnology 2.4k
- Infectious Diseases 1.5k
Countries citing papers authored by Otto Cars
This map shows the geographic impact of Otto Cars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Cars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Cars more than expected).
Fields of papers citing papers by Otto Cars
This network shows the impact of papers produced by Otto Cars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Cars. The network helps show where Otto Cars may publish in the future.
Co-authorship network of co-authors of Otto Cars
This figure shows the co-authorship network connecting the top 25 collaborators of Otto Cars. A scholar is included among the top collaborators of Otto Cars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto Cars. Otto Cars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments. | 1 |
| 3 | 41 | |
| 4 | 15 | |
| 5 | 46 | |
| 6 | 12 | |
| 7 | 498 | |
| 8 | 285 | |
| 9 | 29 | |
| 10 | 69 | |
| 11 | 7 | |
| 12 | 34 | |
| 13 | 13 | |
| 14 | 12 | |
| 15 | 17 | |
| 16 | 10 | |
| 17 | [Comments from STRAMA: Contradictory Norwegian guidelines for the treatment of tonsillitis]. | 1 |
| 18 | 16 | |
| 19 | 5 | |
| 20 | New immunofluorescence method for the identification of group A, B, C, E, F, and G streptococci. | 4 |
About Otto Cars
Otto Cars is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 186 papers that have together received 9.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (99 papers), Antibiotic Resistance in Bacteria (83 papers) and Pneumonia and Respiratory Infections (45 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.4k citations), Molecular Medicine (4.5k citations) and Pharmacology (4.3k citations). Otto Cars has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Elisabeth Löwdin, Inga Odenholt, Johan W. Mouton, Lena E. Friberg, Carl Nathan, Dominique L. Monnet, Christian G. Giske, Hartmut Derendorf, Elisabet I. Nielsen and Michael N. Dudley. Their work appears in journals such as New England Journal of Medicine, The Lancet and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.